Date | Subject |
---|
2022-12-29 21:18:49 | Good morning! #premarket #watchlist 12/30 $PALI -old news+big volume(+96%), $TUEM -old news+big volume(+68%), $KALA -old news+legendary runner (+43%), $DRMA - no news+big volume(+90%) |
2022-12-28 21:54:56 | Good morning! #premarket #watchlist 12/29 $QTNT -no news+big volume(+90%), $BXRX -old news+big volume(+80%), $KALA -old news+recent runner (+40%) |
2022-12-27 21:36:23 | Good morning! #premarket #watchlist 12/28 $JNCE -Gilead buys out rights to cancer therapy from Jounce for $67 million(+73%), $LUCY -Announces Multi-Year, Global Licensing Agreement(+65%), $KALA -Announces FDA Acceptance of IND Application for KPI-012 for the Treatment of PCED (+50%) |
2022-12-27 21:33:03 | Good morning! #premarket #watchlist 12/28 $JNCE -Gilead buys out rights to cancer therapy from Jounce for $67 million(+73%), $LUCY -Announces Multi-Year, Global Licensing Agreement(+65%), $KALA -Announces FDA Acceptance of IND Application for KPI-012 for the Treatment of PCED (+50%) |